跳至主要内容
临床试验/NCT04276012
NCT04276012Unknown不适用

Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia: PRISCA Study

Dr. Pere Roura-Poch2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2020年1月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
130
试验地点
2
主要终点
Changes in global cardiovascular risk

研究概览

简要总结

The main objective is to determine the effectiveness of a program which consists of multidisciplinary, intensive and individualized interventions, carried out by a group of health professionals (psychiatrist, psychologist, mental health nurse, primary care doctors, pharmacist), during six-month, to improve the global cardiovascular risk (CVR) in patients with schizophrenia. Secondarily, will be analyzed the effectiveness of this program on improving the control in four selected cardiovascular risk factors: hypertension, hypercholesterolemia, hyperglycaemia and smoking, after 6 months Methods: randomized study with parallel assignment in two groups: control and intervention group, six-month follow-up. The eligible patients will be 130 adult (≥18 years) outpatients with a current diagnosis of schizophrenia who follow-up by health mental network in Catalonia, who presents at least bad control in one of the four selected cardiovascular risk factors. The intervention group will receive a multidisciplinary and individualized approach (psychoeducational, recommendations of life style and diet, medication adherence and changes in pharmacological strategy, depending on the individual needs assessing after cardiovascular risk screening. The control group will follow the standard management according to the primary care professionals' team.

Main measurements: the global CVR at baseline and at six-month follow-up through Framingham tables calibrated for the Catalan population (Registre Gironí del Cor, REGICOR). Secondary measures: they will be determined, at baseline and at six-month follow-up, four cardiovascular risk factors as well: hypertension, hypercholesterolemia, hyperglycaemia and smoking, according with the latest recommendations of the Program of preventive activities and health promotion (PAPPS) of the Spanish Society of Family and Community Medicine. Other measures: anthropometric parameters. Functional Assessment Screening Tool (FAST) and quality of life (EQ-5D).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults (≥18 years of age), outpatient, current diagnostic of schizophrenia, follow-up by mental health network in Catalonia, signed informed consent.

排除标准

  • other severe mental illnesses different from schizophrenia, patients with intellectual disabilities or clinical acute psychotic relapse

结局指标

主要结局

Changes in global cardiovascular risk

时间窗: At six months

Framingham tables calibrated for the Catalan population (Registre Gironí del Cor, REGICOR). The CVR was stratified into the following groups:\<5%, low; 5-9%, moderate; 10-14%, high; and ≥15, very high.

次要结局

  • Stopping tobacco(At six months)
  • Changes in systolic/diastolic blood pressure(At six months)
  • Changes in cholesterolemia level and other lipids in blood(At six months)
  • Changes in glycated haemoglobin(At six months)

研究者

发起方
Dr. Pere Roura-Poch
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Pere Roura-Poch

Epidemiologist

Consorci Hospitalari de Vic

研究点 (2)

Loading locations...

相似试验